TWST
HOLD / NEUTRALMeanRevComposite
52.30
Technical
97.60
Fundamental
37.20
Rank
—
Price
151.42
Hurst
0.35
As of
Aug 26, 2026
Daily
Twist Bioscience Corporation
HealthcareBiotechnologyTwist Bioscience manufactures synthetic DNA and related molecular products used across therapeutics, diagnostics, materials science, agriculture, and academic research sectors. Its portfolio includes synthetic genes and oligonucleotide pools for applications like gene editing and sequencing, as well as diagnostic tools such as NGS kits and methylation detection assays for disease research. The company also produces viral reference controls and antibody engineering solutions for drug development, serving biotech, pharmaceutical, chemical, agricultural, and research institutions.
Market cap
$10.3B
P/E (trailing)
—
P/E (forward)
-245.94
PEG ratio
—
Dividend yield
—
Beta
2.22
52w range
23.30 – 163.70
Return on equity
-29.59%
Profit margin
-31.66%
Revenue growth
+23.20%
Earnings growth
—
Price history
1Y: 155.56 (+456.6%) · range 25.45–155.56
Cycle position
71/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 10 · NOT READY · exit proximity 70
Conviction
21/ 100 · maturity 100%
VScore.4023
Buildup.2017
EMA entry setup.2510
Fundamentals.1537
Volume profile
POC
58.41
Price vs POC
+166.3%
Overhead supply
1%
Runway
open sky
Value area 42.68–103.19 · 1% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| squeeze-risk | 0.475 | Sep 17, 2026 |
| short-interest | 0.318 | Sep 17, 2026 |
| trend-signal | 0.317 | Sep 17, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -15.22% | +2.03% | 11/20d |
| 40d | -15.22% | +2.03% | 11/40d |